Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria.

Smita A Kshirsagar1, Terrence F Blaschke, Lewis B Sheiner

  • 1Department of Medicine, Stanford University Medical Center, Stanford, CA, USA.

Journal of Pharmacokinetics and Pharmacodynamics
|September 28, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of Oral Amoxicillin for the Treatment of Syphilis in Pregnancy.

Open forum infectious diseases·2026
Same author

Valacyclovir Treatment in Mild Cognitive Impairment: The VALMCI Randomized Clinical Trial.

Alzheimer disease and associated disorders·2026
Same author

Oseltamivir drug-disease modelling in infants with influenza virus infection.

British journal of clinical pharmacology·2026
Same author

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis.

The European respiratory journal·2026
Same author

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.

The New England journal of medicine·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Automated methods for cleaning clinical trial data, like the Lu et al. technique, may miss important drug exposure-toxicity relationships. Rigorous testing and clinical judgment are essential for reliable pharmacokinetic analysis.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Clinical Trial Data Analysis
  • HIV/AIDS Therapeutics

Background:

  • Clinical trial data often suffers from issues like patient non-compliance and data recording errors, complicating pharmacokinetic (PK) analysis.
  • Existing methods aim to identify and address unreliable dosing history in PK datasets.
  • Indinavir (IDV) is an antiretroviral drug used in HIV treatment, with known nephrotoxicity linked to high drug exposure.

Purpose of the Study:

  • To evaluate an automated method (Lu et al.) for cleaning pharmacokinetic data by detecting non-compliance.
  • To compare the reliability of an automated cleaning method versus traditional clinical inspection for identifying exposure-toxicity relationships.
  • To assess the impact of data cleaning on the relationship between indinavir (IDV) pharmacokinetics and nephrotoxicity in HIV-1 patients.

Related Experiment Videos

Main Methods:

  • An automated non-compliance detection method was implemented using NONMEM software (beta) VI.
  • A dataset of indinavir (IDV) plasma concentrations from HIV-1 infected patients was cleaned using both the automated method and manual inspection in Microsoft Excel based on clinical PK criteria.
  • A one-compartment PK model was fitted to both cleaned datasets to estimate population PK parameters and evaluate exposure-toxicity relationships.

Main Results:

  • Population PK parameters for IDV were similar across both cleaning methods and consistent with previous findings.
  • The automated 'compliance cleaned' dataset failed to identify previously established exposure-toxicity relationships for IDV.
  • The 'PK cleaned' dataset (manual inspection) revealed significant differences in oral clearance, apparent volume, and maximum concentration (Cmax) associated with nephrotoxicity and nephrolithiasis.

Conclusions:

  • The automated non-compliance detection method did not improve data reliability over traditional clinical criteria and potentially obscured important exposure-toxicity signals.
  • Automated data cleaning methods require rigorous validation with real-world datasets and should be used cautiously alongside clinical reasoning.
  • Clinical judgment remains crucial in pharmacokinetic data analysis to ensure accurate identification of drug safety and efficacy relationships.